News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) Prepares to Raise Genzyme Corporation Bid as GlaxoSmithKline Denies Plans to Step in as Rival Bidder
September 7, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS, Sept 7 (Reuters) - GlaxoSmithKline (GSK.L) will not step in as a rival bidder for U.S. biotech Genzyme (GENZ.O) and take on Sanofi-Aventis (SASY.PA), the British drugmaker's head of research and development told a French newspaper.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
GlaxoSmithKline
Sanofi (France)
MORE ON THIS TOPIC
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
·
2 min read
·
Heather McKenzie
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
September 2, 2025
·
1 min read
·
Annalee Armstrong
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
·
1 min read
·
Jef Akst
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
August 27, 2025
·
2 min read
·
Annalee Armstrong